Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Dutasteride injections can help treat hair loss in men and women.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

New biomarkers and targets for breast cancer treatment were identified to help prevent relapse and metastasis.

Using dutasteride during hair transplants improves results and reduces hair loss.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Natural products can help overcome cancer drug resistance.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The scaffold effectively prevents melanoma relapse and aids wound healing.

Finasteride may affect PNMT, causing side effects.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

Chemotherapy and certain hair care practices can cause severe hair matting.